Subclinical signs in LRRK2 mutation carriers

被引:24
|
作者
Johansen, Krisztina K. [1 ,2 ]
White, Linda R. [1 ,2 ]
Farrer, Matthew J. [3 ]
Aasly, Jan O. [1 ,2 ]
机构
[1] St Olavs Univ Hosp, Dept Neurol, N-7006 Trondheim, Norway
[2] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway
[3] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
关键词
Parkinson's disease; G2019S; N1437H; Premotor; Hyposmia; LRRK2-ASSOCIATED PARKINSONS-DISEASE; DOPAMINERGIC DYSFUNCTION; CLINICAL-DIAGNOSIS; PROGRESSION; ACCURACY; FEATURES; PHASE; RISK;
D O I
10.1016/j.parkreldis.2011.04.014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Several non-motor features have been reported to precede the motor signs of Parkinson's disease (PD) by several years. However, the time of onset of non-motor and motor symptoms is still debated. Healthy individuals carrying a PD-related mutation are candidates for studying the earliest disease signs. Objectives: To describe clinically healthy family members of PD patients carrying a LRRK2 mutation (LRRK2-PD). Methods:A total of 47 family members of LRRK2-PD patients were included in the present study and were screened for the p.G2019S and p.N1437H substitutions in the LRRK2 gene. A standardized case report form was filled out in each case, including general medical evaluation, neurological examination with UPDRS, an olfaction test, mood, sleep and cognitive questionnaires. Results: Thirty-two study participants were positive, and 15 were negative for a LRRK2 mutation. Higher UPDRS motor scores, more frequent reports of urinary problems, and fewer hours of sleep were found in mutation carriers compared to non-carriers. The mutation carriers with UPDRS >= 8 were all aged over 50 years, had shorter overall sleeping hours, more frequent urinary and constipation problems, higher mood scores and body mass index. Deterioration of olfaction was not detected in either group. Conclusion: Healthy LRRK2 mutation carriers presented subclinical parkinsonian motor and non-motor signs in the apparent absence of olfactory loss. Longitudinal studies will determine whether these changes precede alterations detectable by neuroimaging. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:528 / 532
页数:5
相关论文
共 50 条
  • [21] Association of Total Bilirubin with Motor Signs in Early Parkinson’s Disease in LRRK2 Variant Carriers
    Danial Kazemi
    Hamed Hajishah
    Amir Shayan Chadeganipour
    Journal of Molecular Neuroscience, 2022, 72 : 2338 - 2344
  • [22] Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?
    Saunders-Pullman, Rachel
    Mirelman, Anat
    Wang, Cuiling
    Alcalay, Roy N.
    Luciano, Marta San
    Ortega, Robert
    Raymond, Deborah
    Mejia-Santana, Helen
    Ozelius, Laurie
    Clark, Lorraine
    Orr-Utreger, Avi
    Marder, Karen
    Giladi, Nir
    Bressman, Susan B.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2014, 1 (09): : 670 - 678
  • [23] REM Sleep Behavior Disorder, as Assessed by Questionnaire, in G2019S LRRK2 Mutation PD and Carriers
    Saunders-Pullman, Rachel
    Alcalay, Roy N.
    Mirelman, Anat
    Wang, Cuiling
    Luciano, Marta San
    Ortega, Roberto A.
    Glickman, Amanda
    Raymond, Deborah
    Mejia-Santana, Helen
    Doan, Nancy
    Johannes, Brooke
    Yasinovsky, Kira
    Ozelius, Laurie
    Clark, Lorraine
    Orr-Utreger, Avi
    Marder, Karen
    Giladi, Nir
    Bressman, Susan B.
    MOVEMENT DISORDERS, 2015, 30 (13) : 1834 - 1839
  • [24] Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism
    Ross, Owen A.
    Spanaki, Cleanthe
    Griffith, Alida
    Lin, Chin-Hsien
    Kachergus, Jennifer
    Haugarvoll, Kristoffer
    Latsoudis, Helen
    Plaitakis, Andreas
    Ferreira, Joaquim J.
    Sampaio, Cristina
    Bonifati, Vincenzo
    Wu, Ruey-Meei
    Zabetian, Cyrus P.
    Farrer, Matthew J.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 (06) : 466 - 467
  • [25] Exercise knowledge, barriers and motivators among LRRK2 G2019S mutation carriers
    Schootemeijer, S.
    Coker, D.
    Shelton, J. F.
    Chanoff, E.
    Rowbotham, H. M.
    Darweesh, S. K. L.
    Bloem, B. R.
    Cannon, P.
    de Vries, N. M.
    PARKINSONISM & RELATED DISORDERS, 2023, 113
  • [26] Network abnormalities among non-manifesting Parkinson disease related LRRK2 mutation carriers
    Jacob, Yael
    Rosenberg-Katz, Keren
    Gurevich, Tanya
    Helmich, Rick C.
    Bloem, Bastiaan R.
    Orr-Urtreger, Avi
    Giladi, Nir
    Mirelman, Anat
    Hendler, Talma
    Thaler, Avner
    HUMAN BRAIN MAPPING, 2019, 40 (08) : 2546 - 2555
  • [27] High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2*relaxometry
    Pyatigorskaya, Nadya
    Sharman, Michael
    Corvol, Jean-Christophe
    Valabregue, Romain
    Yahia-Cherif, Lydia
    Poupon, Fabrice
    Cormier-Dequaire, Florence
    Siebner, Hartwig
    Klebe, Stephan
    Vidailhet, Marie
    Brice, Alexis
    Lehericy, Stephane
    MOVEMENT DISORDERS, 2015, 30 (08) : 1077 - 1084
  • [28] Nigral and Striatal Connectivity Alterations in Asymptomatic LRRK2 Mutation Carriers: A Magnetic Resonance Imaging Study
    Vilas, Dolores
    Segura, Barbara
    Baggio, Hugo C.
    Pont-Sunyer, Claustre
    Compta, Yaroslau
    Valldeoriola, Francesc
    Jose Marti, Maria
    Quintana, Maria
    Bayes, Angels
    Hernandez-Vara, Jorge
    Calopa, Matilde
    Aguilar, Miquel
    Junque, Carme
    Tolosa, Eduardo
    MOVEMENT DISORDERS, 2016, 31 (12) : 1820 - 1828
  • [29] Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers
    Thaler, Avner
    Mirelman, Anat
    Helmich, Rick C.
    van Nuenen, Bart F. L.
    Rosenberg-Katz, Keren
    Gurevich, Tanya
    Orr-Urtreger, Avi
    Marder, Karen
    Bressman, Susan
    Bloem, Bastiaan R.
    Giladi, Nir
    Hendler, Talma
    CORTEX, 2013, 49 (09) : 2501 - 2511
  • [30] Perspective on the current state of the LRRK2 field
    Taymans, Jean-Marc
    Fell, Matt
    Greenamyre, Tim
    Hirst, Warren D.
    Mamais, Adamantios
    Padmanabhan, Shalini
    Peter, Inga
    Rideout, Hardy
    Thaler, Avner
    NPJ PARKINSONS DISEASE, 2023, 9 (01)